Brian Lindsay, MD
Pulmonary Disease · Cedar Rapids, IANPI 1508008566
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 85.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $655 and has fallen 86.1% since, to $91 in 2024. That places this record below the midpoint for pulmonary disease clinicians in IA, where the typical reported total is $578.
Across 11 payments — averaging $72.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$677
- ERBE USA Inc$53
- Conmed Corporation$33
- Insmed, Inc.$16
- Pulmonx Corporation$13
What the payments were for
- Travel & lodging$46759%
- Food & beverage$31039%
- Education$162%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $677 |
| ERBE USA Inc | 2 | $53 |
| Conmed Corporation | 1 | $33 |
| Insmed, Inc. | 1 | $16 |
| Pulmonx Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$793 in reported general payments places this provider in the 50th percentile of 110 pulmonary disease providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 466 | $336,152 |
| Dupixent PenDupilumab | 79 | $307,296 |
| AdempasRiociguat | 12 | $166,363 |
| Fasenra PenBenralizumab | 29 | $163,956 |
| Breo ElliptaFluticasone/Vilanterol | 293 | $140,574 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 234 | $127,030 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 209 | $112,181 |
| SymbicortBudesonide/Formoterol Fumarate | 247 | $70,349 |
| NucalaMepolizumab | 19 | $69,004 |
| Spiriva HandihalerTiotropium Bromide | 83 | $68,707 |
| Advair HfaFluticasone Propion/Salmeterol | 137 | $65,918 |
| Spiriva RespimatTiotropium Bromide | 93 | $58,400 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 69 | $46,107 |
| Incruse ElliptaUmeclidinium Bromide | 98 | $40,313 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 88 | $37,141 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Cedar Rapids
- Syed ShahCedar Rapids$12K
- Hamad AzamCedar Rapids$9K
- Vijaya GogineniCedar Rapids$5K
- Hafiz HashmiCedar Rapids$4K
- Giovanni Cordoba SolisCedar Rapids$2K
- Bryan KrajicekCouncil Bluffs$470K
- Sumit MukherjeeCouncil Bluffs$264K
- John SouthardCouncil Bluffs$184K
- Dustin McCannWest Des Moines$67K
- Alejandro ComellasIowa City$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.